Cargando…

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD

OBJECTIVE: To evaluate the impact of lung function, measured as forced expiratory volume in 1 second (FEV(1)) % predicted, on health care resource utilization and costs among patients with COPD in a real-world US managed-care population. METHODS: This observational retrospective cohort study utilize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Xuehua, Marvel, Jessica, Yu, Tzy-Chyi, Wertz, Debra, Geremakis, Caroline, Wang, Liya, Stephenson, Judith J, Mannino, David M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968671/ https://www.ncbi.nlm.nih.gov/pubmed/27555759 http://dx.doi.org/10.2147/COPD.S108967

Ejemplares similares

Economic Burden of COPD in the Presence of Comorbidities
por: Mannino, David M., et al.
Publicado: (2015)

The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis
por: Martin, Amber L., et al.
Publicado: (2016)

COPD exacerbation frequency and its association with health care resource utilization and costs
por: Dhamane, Amol D, et al.
Publicado: (2015)

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting
por: Stephenson, Judith J, et al.
Publicado: (2017)

Lung microbiology and exacerbations in COPD
por: Beasley, Victoria, et al.
Publicado: (2012)

Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population
por: Moll, Keran, et al.
Publicado: (2015)

Acute exacerbation of COPD: is it the “stroke of the lungs”?
por: Hillas, Georgios, et al.
Publicado: (2016)

Utility of the CAT in the therapy assessment of COPD exacerbations in China
por: Tu, You-Hui, et al.
Publicado: (2014)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
por: Ke, Xuehua, et al.
Publicado: (2018)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
por: Rajagopalan, Krithika, et al.
Publicado: (2018)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Clinical diaries in COPD: compliance and utility in predicting acute exacerbations
por: Walters, E Haydn, et al.
Publicado: (2012)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Survival Impact of Current-Smoking-Related COPD or COPD with Acute Exacerbation on Bladder Preservation through Concurrent Chemoradiotherapy for Muscle-Invasive Bladder Urothelial Carcinoma
por: Zhang, Jiaqiang, et al.
Publicado: (2021)

Impact of Hyponatremia on COPD Exacerbation Prognosis
por: García-Sanz, María-Teresa, et al.
Publicado: (2020)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Trend of cost and utilization of COPD medication in Korea
por: Lee, Jongmin, et al.
Publicado: (2016)

Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients
por: Erdal, Marta, et al.
Publicado: (2016)

The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD
por: Alqahtani, Jaber S., et al.
Publicado: (2021)

Association between lung function and exacerbation frequency in patients with COPD
por: Hoogendoorn, Martine, et al.
Publicado: (2010)

Can resistive breathing injure the lung? Implications for COPD exacerbations
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2016)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Rising total costs and mortality rates associated with admissions due to COPD exacerbations
por: Molinari, Nicolas, et al.
Publicado: (2016)

Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma
por: Gagnat, Ane Aamli, et al.
Publicado: (2020)

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA
por: Hanania, Nicola A, et al.
Publicado: (2023)

Impact of anxiety and depression on the prognosis of copd exacerbations
por: Sandra, Martínez-Gestoso, et al.
Publicado: (2022)

Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
por: Crooks, Michael G., et al.
Publicado: (2021)

COPD exacerbation: Lost in translation
por: Makris, Demosthenes, et al.
Publicado: (2009)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Exacerbations in COPD Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2017)

Impaired Hemorheology in Exacerbations of COPD
por: Ugurlu, Erhan, et al.
Publicado: (2017)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9btp4m72h4npsb3t6nv9u0qjtd